Onconetix, Inc.
No trades
No trades
Compare with Onconetix, Inc.
−199.1005 USD
−14.03 M USD
815.37 K USD
3.94 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Company info
Sector
Industry
CEO
David Allan White
Website
Headquarters
Cincinnati
Founded
2018
ISIN
US68237Q4010
CUSIP
68237Q401
FIGI
BBG00PNSYQJ2
Identifiers
ISIN US68237Q4010
Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The company was founded in October 2018 and is headquartered in Cincinnati, OH.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of ONCO is 0.7564 USD — it has decreased by −3.30% in the past 24 hours. Watch Onconetix, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Onconetix, Inc. stocks are traded under the ticker ONCO.
ONCO stock has risen by 2.42% compared to the previous week, the month change is a −20.23% fall, over the last year Onconetix, Inc. has showed a −99.46% decrease.
ONCO reached its all-time high on Feb 22, 2022 with the price of 15,453,000.0000 USD, and its all-time low was 0.5868 USD and was reached on Aug 31, 2026. View more price dynamics on ONCO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ONCO stock is 6.16% volatile and has beta coefficient of −0.42. Track Onconetix, Inc. stock price on the chart and check out the list of the most volatile stocks — is Onconetix, Inc. there?
Today Onconetix, Inc. has the market capitalization of 2.99 M, it has increased by 6.69% over the last week.
Yes, you can track Onconetix, Inc. financials in yearly and quarterly reports right on TradingView.
Onconetix, Inc. is going to release the next earnings report on Nov 12, 2026. Keep track of upcoming events with our Earnings Calendar.
ONCO net income for the last quarter is −2.87 M USD, while the quarter before that showed −4.21 M USD of net income which accounts for 0.00% change. Track more Onconetix, Inc. financial stats to get the full picture.
No, ONCO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 13, 2026, the company has 8 employees. See our rating of the largest employees — is Onconetix, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Onconetix, Inc. EBITDA is −7.67 M USD, and current EBITDA margin is −776.30%. See more stats in Onconetix, Inc. financial statements.
Like other stocks, ONCO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Onconetix, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Onconetix, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Onconetix, Inc. stock shows the sell signal. See more of Onconetix, Inc. technicals for a more comprehensive analysis.